What is the compound annual growth rate forecast for biological CDMO manufacturing over the next seven years?
Answered at 6:34 in Why Procurement Can Make or Break a Drug Company · Executive Edge Podcast
What is the compound annual growth rate forecast for biological CDMO manufacturing over the next seven years?
The CDMO marketplace is hundreds of billions in total, and biologics manufacturing is forecasted to grow at a compound annual growth rate of 8 to 12% over the next seven years, reflecting rapid growth in the global manufacturing of these drugs.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
The CDMO marketplace is hundreds of billions in total, and biologics manufacturing is forecasted to grow at a compound annual growth rate of 8 to 12% over the next seven years, reflecting rapid growth in the global manufacturing of these drugs.
Dave Stowe, Founder and Managing Partner at Adventus · Why Procurement Can Make or Break a Drug Company · Executive Edge Podcast · answer at 6:34
Key takeaways
- The CDMO marketplace is hundreds of billions in total, and biologics manufacturing is forecasted to grow at a compound annual growth rate of 8 to 12% over the next seven years, reflecting rapid growth in the global manufacturing of these drugs.
Quote to remember
“There's always this challenge, right? It's a game of capacity management. You know, you can imagine you're buying capacity at the CDMO. They could sell it to somebody else.”
— Dave Stowe
The full answer · about 1 min
The CDMO marketplace is hundreds of billions in total, and biologics manufacturing is forecasted to grow at a compound annual growth rate of 8 to 12% over the next seven years, reflecting rapid growth in the global manufacturing of these drugs.
Key facts
- 37% of global chemicals in pharmaceutical manufacturing originate from China
- CDMO biologics manufacturing forecasted at 8 to 12% compound annual growth rate over seven years
- Drug development timeline: 2 to 5 to 10 years from preclinical through full production
- Radioisotope half-life example: 5-day half-life requiring overnight shipping from Indiana to patient administration
- Injectable syringe viscosity requirement: under 5 to 10 milliliters
People, companies and topics mentioned
More answers from this episode
- 5:04What are the key starting materials in pharmaceutical manufacturing and how do they flow through the global supply chain?
- 5:44What percentage of global key starting materials in pharmaceutical manufacturing originate from China?
- 10:16How long does it typically take to develop and scale a drug from preclinical through full production?
- 11:00Why does the location of a CDMO facility impact drug delivery to market?
- 15:48What regulatory oversight tools are available to evaluate CDMO quality and compliance before selection?